Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.

OBJECTIVE The purpose of this study was to investigate the prevalence of hepatic steatosis in an asymptomatic U.S. adult population using attenuation values at unenhanced CT as the reference standard. We also assessed the utility of known clinical risk factors for diagnosis. MATERIALS AND METHODS For 3,357 consecutive asymptomatic adults (1,865 women and 1,492 men; mean age, 57.0 years), hepatic and splenic CT attenuation values (Hounsfield units) were obtained by unenhanced CT using a low-dose colonography technique for colorectal cancer screening. Multiple attenuation criteria for steatosis were applied, including liver thresholds and comparison of liver and spleen attenuation. Relevant clinical risk factors were compared against a CT liver attenuation < or = 40 HU, which has been shown to exclude mild steatosis. RESULTS Mean liver attenuation was 58.8 +/- 10.8 (SD) HU. The prevalence of moderate-to-severe hepatic steatosis (defined by liver attenuation < or = 40 HU) was 6.2% (208/3,357). For CT attenuation criteria that include milder degrees of steatosis, prevalence increased to as high as 45.9% (1,542/3,357) for a liver-to-spleen attenuation ratio of < or = 1.1. Overweight status (body mass index > 25) was a sensitive indicator for moderate-to-severe steatosis (92.8%) but was highly nonspecific (37.5%). Other clinical risk factors, such as diabetes, dyslipidemia, hypertension, alcohol overuse, and hepatitis, were more specific (77.6-92.4%) but highly insensitive (1.9-37.5%). Combining clinical risk factors did not substantially increase the accuracy for screening. CONCLUSION Assessment of liver attenuation by use of unenhanced CT represents an objective and noninvasive means for detection of asymptomatic hepatic steatosis, whereas clinical risk factor assessment is unreliable. Further longitudinal investigation is needed to determine the most appropriate attenuation threshold and the risk for disease progression to steatohepatitis and cirrhosis.

[1]  Alex P. Reiner,et al.  Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study , 2012, European journal of gastroenterology & hepatology.

[2]  S. Park,et al.  Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis , 2012, European Radiology.

[3]  K. Takaoka,et al.  ACL reconstruction using bone‐tendon‐bone graft engineered from the semitendinosus tendon by injection of recombinant BMP‐2 in a rabbit model , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  T. Vogl,et al.  Detection of a fatty liver after binge drinking: correlation of MR-spectroscopy, DECT, biochemistry and histology in a rat model. , 2011, Academic radiology.

[5]  C. Kauffmann,et al.  Fatty liver deposition and sparing: a pictorial review , 2011, Insights into imaging.

[6]  S. Park,et al.  Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. , 2011, Radiology.

[7]  A. Gamst,et al.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. , 2009, Radiology.

[8]  Boris Guiu,et al.  Multiecho MR imaging and proton MR spectroscopy for liver fat quantification. , 2008, Radiology.

[9]  David J Vanness,et al.  Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. , 2008, Radiology.

[10]  J. Hirschhorn,et al.  Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study , 2008, Journal of gastroenterology and hepatology.

[11]  Perry J Pickhardt,et al.  Computed tomographic colonography to screen for colorectal cancer, extracolonic cancer, and aortic aneurysm: model simulation with cost-effectiveness analysis. , 2008, Archives of internal medicine.

[12]  L. Katsnelson,et al.  Interobserver and intraobserver variability in the sonographic assessment of fatty liver. , 2007, AJR. American journal of roentgenology.

[13]  David H. Kim,et al.  CT colonography versus colonoscopy for the detection of advanced neoplasia. , 2007, The New England journal of medicine.

[14]  S. Curley,et al.  Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.

[15]  P. Angulo.  GI Epidemiology: nonalcoholic fatty liver disease , 2007, Alimentary pharmacology & therapeutics.

[16]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[17]  Sang Won Lee,et al.  Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.

[18]  Y. Cho,et al.  Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults , 2006, Journal of gastroenterology and hepatology.

[19]  T. Omatsu,et al.  The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease , 2006, Annals of Internal Medicine.

[20]  Shi-yao Chen,et al.  Fatty liver and the metabolic syndrome among Shanghai adults , 2005, Journal of gastroenterology and hepatology.

[21]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[22]  Lennart Bodin,et al.  Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting , 2005, Modern Pathology.

[23]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[24]  Yoshimasa Kusano,et al.  Prevalence of fatty liver in Japanese children and relationship to obesity , 1995, Digestive Diseases and Sciences.

[25]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[26]  P Christoffersen,et al.  Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.

[27]  S. Caldwell,et al.  The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. , 2004, Journal of hepatology.

[28]  L. Friedman.  Controversies in liver biopsy: Who, where, when, how, why? , 2004, Current gastroenterology reports.

[29]  James Sayre,et al.  Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. , 2004, Radiology.

[30]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[31]  Mauro Salizzoni,et al.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.

[32]  R. Brasch,et al.  Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. , 2001, AJR. American journal of roentgenology.

[33]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[34]  S. Malnick,et al.  Fatty liver--an additional and treatable feature of the insulin resistance syndrome. , 1999, QJM : monthly journal of the Association of Physicians.

[35]  G. Minuk,et al.  Clinical hepatology: Profile of an urban, hospital‐based practic , 1996, Hepatology.

[36]  M. Bennett,et al.  The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.

[37]  C. Tiribelli,et al.  Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis , 1995, Journal of magnetic resonance imaging : JMRI.

[38]  C. Day,et al.  The biochemistry of alcohol-induced fatty liver. , 1994, Biochimica et biophysica acta.

[39]  C. Thomsen,et al.  Quantification of liver fat using magnetic resonance spectroscopy. , 1994, Magnetic resonance imaging.

[40]  C. Tiribelli,et al.  Fatty Infiltration of the Liver: Quantification by 1H Localized Magnetic Resonance Spectroscopy and Comparison with Computed Tomography , 1993, Investigative radiology.

[41]  J. Boyer,et al.  Outpatient Liver Biopsy: How Safe Is It? , 1993, Annals of Internal Medicine.

[42]  R. Buxton,et al.  Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. , 1991, AJR. American journal of roentgenology.

[43]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[44]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[45]  Randall G. Lee,et al.  Nonalcoholic steatohepatitis: a study of 49 patients. , 1989, Human pathology.

[46]  R. Hultcrantz,et al.  Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. , 1986, Scandinavian journal of gastroenterology.

[47]  I. Suramo,et al.  Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. , 1983, Scandinavian journal of gastroenterology.

[48]  P. Christoffersen,et al.  Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties. , 1977, Scandinavian journal of gastroenterology.

[49]  C. R. Hill,et al.  Gray Scale Ultrasound Imaging , 1976 .